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Background: During pregnancy, Plasmodium falciparum-induced malaria can cause placental lesions and intrauterine
growth restriction (IUGR). There are few published studies on Plasmodium vivax-induced malaria in pregnancy. Ultrasound
is an efficient method for evaluating foetal biometry and placenta. The present study aimed to investigate the occurrence
of increased placental thickness, foetal biometry and the amniotic fluid via ultrasound in a cohort of pregnant women
with vivax malaria in Manaus, Amazonas, Brazil.
Methods: A cohort study was conducted among 118 pregnant women with vivax malaria and 191 pregnant women
without malaria. Foetal biometry, placental thicknesses and the amniotic fluid were evaluated via ultrasound. Biometric
data were distributed by the trimester in which the infection occurred and converted to Z scores. The results were
compared between the groups.
Results: Among pregnant women from the cohort, increased placental thickness was observed in ten women with
malaria (8.5 vs 0%; p <0.001). The Z scores of biometric parameters were not statistically significant when comparing
the groups or according to the time of infection. In ultrasound results of the 118 pregnant women with malaria, seven
(6%) showed low foetal weight, two (1.7%) showed oligohydramnios and one (0.85%) showed foetal malformation.
There was no significant difference when these variables were compared to those of the control group.
Conclusions: The placental thickness changes were significant but caused no foetal repercussions at birth. The ultrasound
findings except placental thickness were similar in both groups, possibly because this is a low-endemic area and the
pregnant women in the study were followed up in an active detection system that allowed early diagnosis and treatment
of new malaria episodes.
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Malaria is among the most important public health is-
sues worldwide [1]. In Latin America, it is estimated
four in every 100 pregnancies are affected by malaria,
and there is a high incidence in Brazil [2]. In 2011,
99.7% of malarial transmission was concentrated within
the Amazonian region [1-4], where malaria transmission* Correspondence: mariannabrock@hotmail.com
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parasite species is Plasmodium vivax [1,5,6].
Pregnant women are more susceptible than the general
population to Plasmodium sp. infections [7], and malaria
can convert normal pregnancies into pathological preg-
nancies [8-11]. During pregnancy, Plasmodium falcip-
arum-induced malaria can cause placental lesions and
changes in foetal oxygenation that lead to neonatal im-
pairments, such as intrauterine growth restriction
(IUGR), decreased amniotic fluid, prematurity and brain
injuries caused by hypoxia and intrauterine death
[12-14]. Studies in Thailand, India and Bolivia showed
that compared to non-infected women, P. vivax-infectedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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borns with lower birth weights [3,15-17].
Ultrasound is a useful tool for detecting IUGR and de-
termining the gestational age by foetal biometry [18].
Placental ultrasound can assess the placental thickness,
texture and maturity level, and thus contributes to diag-
noses of placental insufficiency [19,20]. Placental thick-
ness has been associated with various maternal and
foetal conditions, including infections (toxoplasmosis,
rubella, cytomegalovirus, and other infections), diabetes,
anaemia, and hydrops, while decreased placental thick-
ness has been associated with pre-eclampsia, thyroid dis-
ease, placenta insufficiency and IUGR [21-23].
In cases of placental insufficiency and chronic hypoxia,
the foetus adapts to the new situation by protecting its
important organs. This mechanism leads to decreased
diuresis and secretion of pulmonary fluids and subse-
quently leads to oligohydramnios, which is usually de-
tected via ultrasound [24]
There is a lack of studies on ultrasound evaluations of
foetal growth, amniotic fluid and placentas in pregnant
women with vivax malaria. The present study aimed to in-
vestigate the occurrence of changes in placenta, foetal
growth and amniotic fluid volumes by ultrasound in a co-
hort of pregnant women with vivax malaria in Manaus,
Amazonas, Brazil.Methods
A prospective cohort study of pregnant women with and
without vivax malaria, all of whom had gold standard
first trimester ultrasound dating scans (CRL ≤14 wks),
were enrolled from January 2006 to July 2007 in the city
of Manaus at the Dr Heitor Vieira Dourado Tropical
Medicine Foundation (Fundação de Medicina Tropical
Dr Heitor Vieira Dourado; FMT-HVD). This institution is
also a primary care centre, diagnosing and treating pa-
tients with malaria even if they have no clinical complica-
tions. The unexposed group was selected from another
close health unit devoted to antenatal care, attending pa-
tients with the same epidemiological profile in the same
period, matched by maternal age and gestational age at
inclusion.
The unexposed group was recruited in another clinic
because the FMT-HVD is a reference hospital for infec-
tious disease and infections in pregnancy were an ex-
cluding factor in these study (they can lead to IUGR and
other diseases). The study design planned to include
one unexposed woman for each exposed pregnant
woman. Most of the population from Manaus is of
mixed races, therefore, ethnic group was not specified.
Routine blood examinations were performed in all of
them. The same physician performed the ultrasound in
both groups.Malaria diagnosis
The microscopic diagnosis was performed by thick blood
smear in all women. Maternal parasite load was estimated
using a semi-quantitative method as recommended by the
Brazilian Ministry of Health: 200–300 parasites per cu mm;
301–500 parasites/cu mm; 501–10,000 parasites/cu mm;
10,001-100,000 parasites/cu mm and 100,000 or more
parasites/cu mm.
Parasite densities with differential counting of asexual
stages were estimated by experienced microscopists, by
counting the number of parasites in 200 leukocytes in high
magnification fields, and the number of leukocytes/cu mm.
The thick blood smear was performed at the moment
of recruitment and monthly when the patient returned
to antenatal evaluation.
Study procedures
The patients recruited for the study were interviewed
and responded to a questionnaire regarding clinical and
demographic data and were subsequently referred to
ultrasound evaluation. The ultrasound examinations
were performed at the time of the malaria diagnosis and
at 30-day intervals until the delivery date. The examinations
were performed with the GE Voluson Expert and GE P6
devices (GE Healthcare, Little Chalfont, Buckinghamshire,
UK) by a single examiner who was certified in ultrasound
examination by the Brazilian College of Radiology (Colégio
Brasileiro de Radiologia) and the Brazilian Federation of
Gynecology and Obstetrics (Federação Brasileira de
Ginecologia e Obstetrícia) and in Foetal Medicine by the
Brazilian Federation of Gynecology and Obstetrics.
Ultrasound examination
The patients were examined while in the supine position
for bi-dimensional evaluations. They were instructed to
relax the abdominal muscles and not to position the
arms under the head or cross the legs in order to pre-
vent muscle contracture. The gestational age was esti-
mated from the crown-rump length (CRL) during first
trimester ultrasounds, according to the technique re-
ported by Grisolia et al. [25]. During the second and
third trimesters, foetal biometry was based on the biparie-
tal diameter (BPD), head circumference (HC), abdominal
circumference (AC), and femur length (FL) The BPD and
HC were measured according to Campbell and Thoms
[26]; the AC was measured according to Campbell and
Wilkin [27]; and, the FL was measured according to
Kurmanavicius [28]. From 18 to 24 weeks, a foetal mor-
phological study was performed and, in addition to meas-
uring the biometry based on the long bone evaluation as
described above, the tibia, fibula, radius, ulna, foot, and
cerebellum were also measured to evaluate the foetal
morphology. The biometric parameters based on the BPD,
HC, AC, FL, and weight were measured according to the
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each parameter, and the means of the three values were cal-
culated. The professional that performed the ultrasound
knew to which group each pregnant woman belonged.
In an attempt to eliminate problems caused by variations
in the measurements according to the gestational age, the Z
score was used to compare the ultrasound results between
the two groups. When the score was two standard deviations
or more above or below the mean, it was considered altered.
The Z scores were evaluated for all parameters accord-
ing to the following formula: Z = (X-M(GA))/SD(GA),
where X is the measured value (BPD, FL, HC and AC),
M(GA) is the mean of the approximate value for the
evaluated gestational age according to the normality,
and SD(GA) is the standard deviation of the mean for
the gestational age according to the standard curve.
The amniotic fluid was evaluated according to the am-
niotic fluid index (AFI) proposed by Phelan et al. [30].
The placental thickness and location were evaluated at a
perpendicular plan to placental axis at the point of inser-
tion of the umbilical cord, according to Perroti [31]. The
results of placental thickness were presented in milli-
metres. The ultrasound results were analysed with peri-
natal data and data from the unexposed group. It is
important to take into account that after >24 weeks
ultrasound scans are prone to high rates of error on the
measurements, but by using a control group this limita-
tion is minimized. In both groups the following perinatal
data were evaluated: gestational age at birth, birth type,
foetal weight at birth, presence of malformations, and
maternal parity.
In the group of pregnant women with malaria, the
treatment comprised the use of chloroquine (1,500 mg
for three days and then weekly prophylaxis with 300 mg
of chloroquine for 12 weeks), according to the recom-
mendation of the Brazilian Ministry of Health [32]. In
patients diagnosed with anaemia, ferrous sulphate
(200 mg, three times/day) and folic acid (5 mg/day) were
also prescribed according to the recommendation of the
Brazilian Ministry of Health [33].
In both groups, obstetric complications were treated at
the local maternity hospitals in the region, according to
proximity to the patient’s house; the births also occurred
at these hospitals. Approximately one month after deliv-
ery, the patients came back to another medical evalu-
ation, and newborn data such as body weight, Apgar
scores and the presence of complications were collected
from the newborn cards that were filled out at the ma-
ternity hospitals.
Definitions of variables
Vivax malaria: presence of P. vivax on the microscopic
thick film examination;
Maternal anaemia: haemoglobin lower than 11 mg/dl;Maternal weight: measured upon enrolment and at
each antenatal consultation until childbirth. Mother’s
weight prior to pregnancy was based on antenatal
dates. Weight gain was defined as the difference in
maternal weight between the first and last weight
measured at antenatal consultation;
Low ultrasound weight: weight less than the tenth
percentile for the gestational age;
Low weight at birth: weight at birth less than the tenth
percentile for the gestational age. (Newborns birth
weight was measured immediately after birth as
Ministry of Health recommendation) [34];
Pre-term babies: newborns with gestational age less
than 37 weeks according to the first trimester
ultrasound;
IUGR: foetuses at term with low weight (less than the
tenth percentile according to gestational age proposed
by Olsen [35];
Abortion: birth that occurred before 20 weeks of age;
Congenital abnormality: an abnormality that was
present on the ultrasound and diagnosed by the trained
neonatal doctor during the newborn examination;
Increased placental thickness: placenta above the 90th
percentile for the gestational age [36].
Inclusion and exclusion criteria
Patients with pregnancy diagnoses that were confirmed
by a quantitative beta human chorionic gonadotropin
test or an abdominal or transvaginal obstetric ultrasound
during the first trimester, and who agreed to participate
by providing informed, signed consent were included in
the analysis.
Patients with non-vivax malaria, a previous diagnosis
of maternal disease or any other factors that could affect
the foetal growth or morphology of the foetus, such as
hypertension, auto-immune disease, other infection,
multiple pregnancy and diabetes (diagnosed by fasting
blood glucose and/or oral glucose tolerance test), were
excluded from the study. Patients whose gestational age
could not be evaluated correctly because they did not
undergo a first trimester ultrasound and patients who
did not attend the follow-up examinations were also ex-
cluded from the analysis.
Statistical analysis
The results were tabulated with Excel (Microsoft Corpor-
ation, Redmond, WA, USA) and analysed with Epi-Info for
Windows, version 3.5.3 [37] The data were organized and
presented in graphs and tables. The variables were descrip-
tively analysed by calculating the absolute and relative fre-
quencies. For the quantitative variables, the analysis was
performed by observing the minimum and maximum
values and calculating the means. For continuous quantita-
tive data, the Student’s t test was used for normally
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used for non-parametric data. Categorical data were com-
pared with the Chi-square test and Fisher’s exact test when
appropriate.
Ethics statement
The patients were informed about their participation in the
study, and their consent was obtained through informed
consent terms that were signed by the patients or their
legal guardians. The present study was approved by the
Research Ethics Committee of the Fundação de Medicina
Tropical Dr Heitor Vieira Dourado (FMT-HVD) under
protocol number 0836–05.
Results
During the study period, 214 pregnant women with mal-




Age, years 24.2 (+/−1.4) ——
Education
1-4 years 40 33.9
5-8 years 45 38.1






1st trimester 13 11.0
2nd trimester 73 61.8
3rd trimester 32 27.2
Mean gestational age at inclusion (weeks)
1st trimester 9.2 ——
2nd trimester 19.1 ——
3rd trimester 31.1 ——
Hb at inclusion
1st trimester 10.4 –
2nd trimester 11.0 –
3rd trimester 10.9 —
Weigh gain, kg 11.7
Placental thickness (mm)
2nd trimester 22.5 mm (+/− 3.8 mm) —
3rd trimester 34.8 mm (+/− 3.8 mm) —
Ga, gestational age; Hb, haemoglobin.
fi = simple absolute frequency;
A italicized p-value indicates a statistical difference at a 5% significance level.examination. Among the group of pregnant women with
malaria, three were excluded because of multiple preg-
nancy, 50 because of concomitant diseases (hypertension,
other infections during gestation, triploidy, and diabetes),
20 because of falciparum malaria and 23 due to loss to
follow-up (total of patients submitted to analysis was 118).
Among the group of pregnant women without malaria,
six were excluded because of multiple pregnancy, 53 be-
cause of concomitant diseases (hypertension, other infec-
tions and diabetes), and 39 due to loss to follow-up (total
of patients submitted to analysis was 191).
There were no significant differences between the
groups regarding to the mean age, education, parity,
haemoglobin levels, and maternal weight gain during
pregnancy (Table 1). The mean weight gain during preg-
nancy was 11.7 kg for malaria group and 13.2 kg among
the pregnant group without malaria. In the group ofudy population in Amazonas, Brazil
Range No malaria % Range P-value
n = 191
fi
— 14-39 23.5 (+/−1.9 ) ——— 15-39
% 60 31.4% 0.74
% 92 48.1% 0.10
39 20.4% 0.16
% 78 40.8% 0.16
% 51 26.7% 0.65
% 62 32.5% 0.06
% 29 15.3% 0.34
% 112 58.6% 0.95
% 50 26.1% 0.92
— 9.7 ——— 0.15
— 16.9 ——— 0.99
— 31.4 ——— 0.36
7.2-13.5 11.1 — 7.7-13.8 0.38
7.4-14.1 11.5 — 8.0-14.3 0.48
7.6-13.5 11.3 — 8.5-14.1 0.38
5.3-17.2 13.2 8.4-18.6 0.36
— 17.6 mm (+/− 3.7 mm) —— —— 0,000
—— 31.4 mm (+/− 3.9 mm) ——— ————— 0,000
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first episode of malaria in lifetime in this pregnancy.
Parasite load ranged from 501–10,000 parasites/cu mm.
Among the patients with malaria, 13 (11.0%) were in-
cluded during the first trimester of pregnancy, 73
(61.8%) during the second trimester and 32 (27.2%) dur-
ing the third trimester (Table 1).Ultrasound findings
Of the ultrasounds from the 118 pregnant women with
malaria, seven (6%) showed low foetal weights, two
(1.7%) showed oligohydramnios, and one (0.85%)
showed foetal malformation. There was no significant
difference when these variables were compared to those
of the control group. However, increased placental thick-
ness (above placental thickness average table) was only
observed in ten pregnant women with malaria with an-
terior and posterior placenta (8.5%) (p <0.001; Table 2).
Among the patients with increased placental thickness,
five patients had haemoglobin (Hb) levels above 11 mg/
dl and above the malaria group Hb mean (10.9 mg/dl).
This group had no cases of IUGR or low birth weight
and only one patient had pre-term labour with 34 weeks.
None of those patients with increased placental thick-
ness had had oligohydramnios, lateral or fundal placenta.
Data from increased placental thickness group are pre-

















fi = simple absolute frequency; RR = Relative risk; (Confidence level -CI = 95%).
A italicized p-value indicates a statistical difference at a 5% significance level.
+ malformation – harelip *malformation – renal dysplasia.Comparing increased placental thickness group with
placental normal thickness group, there were no statis-
tical differences between maternal age, parity, mean ges-
tational age, Hb levels at presentation, maternal weight
gain, BPD, CC, AC Z-score, birth weight and gestational
age at delivery (Table 3).
Placental analysis revealed a statistically significant in-
crease of thickness in patients with malaria than in the
without malaria group (p <0,01) (Figure 1).Effects of malaria on BPD, HC, AC, FL, HC/AC ratio, and
foetal weight
The ultrasound measurements of foetal growth (BPD, HC,
AC, and FL) in the pregnant women with and without
malaria were compared to the fifth, 50th and 95th percen-
tiles in the daily use tables, according to the proposal by
Hadlock et al. [29]. In both groups, the distributions of
the evaluated parameters were similar throughout all ges-
tational ages.
The Z scores were compared according to the trimes-
ter in which the patients contracted malaria. The first
ultrasonography after malaria diagnosis and the last
ultrasonography before the birth were compared. When
comparing the groups, no significant differences were
found in the mean Z scores of the ultrasounds with re-
gard to the trimester of infection p >0.05 in all parame-
ters (Additional file 2). When the Z score data for alluded in the study
No malaria % RR P-
valuen = 191
fi














Table 3 Comparison between pregnant with and without increased placental thickness





Malaria No malaria n = 191 Totala
n = 108 n = 299
Mean age 24.4 (+/− 1.3) 23.5 (sd+/−1.9) 23.8 21.8 (+/−5.3) 0.13
Primigravida 34 78 112 4 –
Gestational age (weeks) (mean) 21.5 (sd+/−1.8) 19.5 ( sd+/− 1.3) 20.2 (sd+/− 1.5) 22.4 (sd+/− 2.5) 0.40
Wt gain (kg) 11.65 (sd+/−1.6) 13.2 (sd +/− 1.9) 12.6 (sd: +/− 1.8) 12.2 (s/d +/−1.25) 0.67
Hb at presentation 10.9 (+/−0.9) 11.3 (+/−1.2) 11.1 (+/− 1.0) 10.5 (+/− 0.7) 0.69
Avg parasitec 501-10,000 —— ————— 501-10,000 —
N episodes 1.5 ——— —————— 1.6 —
Gest age 1st infection (weeks) 21.5 —— ———— 22.4 0.17
Z score DBP 0.97 0.96 0.96 0.29 0.26
Z score CC 0.02 0.03 0.02 −0.11 0.66
Z score CA 0.22 0.28 0.25 0.17 0.76
Z score F 0.03 0.04 0.03 0.02 0.89
Z score placenta 0.75 −0.26 0.10 1.70 0.000
Birth weight (kg)d 3.158 (sd+/− 465 ) 3.277 (sd+/ -472.5 ) 3.234 (sd+/−468 g) 3.383 (sd+/− 469 g) 0.75
GA at delivery (weeks) 38.5 (+/− 2,2) 38.7 (+/− 2,6) 38.6 (+/− 2,4) 38.8 (+/− 2,2) 0.77
aAll comparisons were made between the groups: increased placental thickness and total of normal placental thickness (malaria normal thickness + no malaria group);
bAll patients had malaria.
cparasites per cu mm;
dBirth weight in grams.
A italicized p-value indicates a statistical difference at a 5% significance level.
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ence (p >0.05).
To evaluate the effect of the malaria exposure time on
foetal changes, survival curves were constructed to ana-
lyse the exposure time (in the group with malaria) or the
inclusion in the study (group without malaria) withFigure 1 Relation between placental thickness z-score and gestational agrespect to impairment in the foetal weight, BPD, HC,
FL, or AC. No significant impairments were found be-
tween the groups and the exposure time (Figure 2). An
analysis with the same parameters according to the tri-
mester of infection was also performed and did not re-
veal any significant differences.e in malaria group (red rhombus) and no malaria group (grey cross).
Figure 2 Survival curves to compare the time of exposure to the occurrence of impairment. A: malaria vs femur length; B: malaria vs abdominal
circumference; C: malaria vs head circumference (HC); D: malaria vs foetal weight. In all graphs: malaria group, blue line; control group, green line.
Cumulative survival was defined as the percentage of foetuses that did not have a measurement <2 SD.
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Table 4 shows the perinatal results. There were no sig-
nificant differences between the malaria-exposed and
unexposed groups with regard to the perinatal results.
Pregnant women with malaria
Among the 118 pregnant women with vivax malaria, 109
(92.4%) initiated treatment on the day of symptom onset.
The other nine initiated treatment up to five days after
symptom onset. All initiated treatment on the same day
of diagnosis of vivax malaria by the thick blood film.Comparing the mean Hb levels with increased placental
thickness, low birth weight or pre-term births there were
no significant difference between the groups of pregnant
women with lower Hb levels and increased placental
thickness (Table 5).
The time to the first ultrasound examination ranged
from 0–15 days after the diagnosis of the symptoms,
with a mean of five days. Sixteen patients evolved with
relapse throughout the follow-up period, however these
patients did not present any ultrasound differences as
compared to those that did not relapse.
Table 4 Included foetal/newborn data from the study population in Amazonas, Brazil
Vivax malaria % Range Malaria % Range RR p-value
negative
n = 118 n = 191
fi fi
Foetal gender
Male 64 54.3% 102 53.5% —————— 0.97
Female 54 45.7% 89 46.5% —————— 0.64
Birth weight 3,177 g (+/−482.5 g) 1,945-4,715 g 3,277 g (+/− 472.5 g) 590-4,290 g —————— 0.33
LBW yes 7 5.9% 18 9.5% 0.71 (0.37-1.36) 0.37
LBW no 111 94.1% 173 90.5%
Malformation 1 0.8% 1 0.8% 1.31 (0.32-5.28) 0.14
Pre-term delivery 19 16% 19 9.9% 0.16
LBW, low birth weight; fi = simple absolute frequency; RR = Relative risk; (Confidence level -CI = 95%).
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The present study evaluates foetal and placental ultra-
sound changes in pregnant women with vivax malaria in
Latin America. Significant differences in the placental
thicknesses between the malaria and non-malaria groups
were revealed via placental ultrasound. Ultrasound stud-
ies of placental thickness have reported that placentas
with increased thicknesses are more likely to be associ-
ated with hydrops, molar pregnancy, other infections
during pregnancy, triploidy, maternal diabetes mellitus,
anaemia and aneuploidy [36,38].
Increased placental thickness does not comprise a spe-
cific diagnosis of any disease. However, it can act as anTable 5 Comparison of haemoglobin levels relative to the
ultrasound findings throughout the pregnancy
Haemoglobin (mg/dL)
Variables <10.9 ≥10.9
fi % fi % Total p
Placental thickness (n = 118)
Yes 5 50 5 50 10 0,381
No 47 43.5 61 56.5 108
USG (n = 118) 0.117
Abnormal findings 23 42.2 37 57.8 60
Normal 29 50 29 50 58
LBW (n = 118) 0.744
Yes 3 42.8 4 57.2 7
No 49 44.2 62 55.8 111
PTL (n = 118) 0.883
Yes 8 44.5 10 55.5 18
No 44 44.0 56 56.0 100
USG, ultrasonography; LBW, low birth weight, PTL, pre-term labour.
fi = simple absolute frequency.alert to identify foetuses at high risk of disease resulting in
inflammation, oedema or compensatory hypertrophy [36].
Lee et al. [21-23] studying placental thickness in the
second trimester found that placental position could
lead to an increased placental thickness. Despite that
placental thickness may vary with the implantation site,
there were no case of fundal or lateral placenta in the in-
creased placental thickness group that would influence
placental thickness.
Godfrey et al. [39] in their study of the effect of mater-
nal anaemia and iron deficiency on the ratio of foetal
weight to placental weight, Agboola [40] studying the ef-
fect of type and duration of anaemia on placental weight
and villous anaemia, Baptiste-Roberts et al. [41] studying
maternal risk factors for abnormal placental growth,
found that increased placental thickness could be result
in foetal hypoxaemia consequent to anaemia stimulating
growth to impaired oxygen transportation [39]. There
was no significant correlation between the pregnant
women with regard to anaemia and increased placental
thickness, and patients with diseases such as diabetes or
infections were excluded from the present study,
strengthening the hypothesis that increased placental
thickness resulted from inflammation or oedema.
When using three-dimensional ultrasound to study
placental volumes in pregnant women with vivax and
falciparum malaria in Thailand, Rijken et al. [42] found
no significant differences between the placental volumes
of the pregnant women with vivax malaria and those
without malaria [42]. No studies have been conducted
on measurements of placental thickness in pregnant
women with malaria, and the existing studies on vivax
malaria and placentas address histopathology and do not
seem to demonstrate that P. vivax causes inflammation
in the intervillous spaces [43,44].
In a study of the effects of placental P. falciparum and
P. vivax infections on placental histopathology in low
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histopathological changes in a small proportion of the
placentas from P. falciparum-infected patients, espe-
cially those who were infected soon before delivery. The
P. vivax infections in this study by McGready et al. [45]
were associated only with the presence of a malarial pig-
ment in some placentas, indicating that prompt and ad-
equate parasitaemia treatment during gestation would
limit placental disease, emphasizing the importance of
treating the infection with anti-malarial drugs during
gestation [45]. Studies that correlate the placental thick-
ness on ultrasound with histopathology should be per-
formed to define the cause of the increased placental
thickness observed in the present study.
The foetal biometry measurements, including BPD, FL,
AC, and foetal weight, are important tools with which to
evaluate gestational age, IUGR and detecting obstetrics
problems. It is fundamental to know the correct gesta-
tional age measured by a first trimester ultrasonography
and compare the foetal biometry and the weight expected
for the gestational age, as was done in this study [46-48].
In the present study, most of the pregnant women de-
veloped malaria during the second and third trimesters
of gestation, and an asymmetric growth restriction with
an abdominal circumference reduction was expected,
but not observed. In both groups, the weights were simi-
lar to those considered adequate in the 50th percentile
for the 38- to 40-week age range, according to a study
by Pedreira et al. on gestational age-based foetal weight
parameters in Brazil [49].
Some studies showed that recently infected women
supposedly have a tendency towards more favourable
perinatal outcomes because of the absence of immuno-
logical memory [7,50,51]. In the present study, most of
the patients were recently infected, and there was no as-
sociation between recent infection and ultrasound or
neonatal changes. Given their existing lower physio-
logical immunity, non-immune pregnant women would
supposedly have a tendency towards a higher susceptibil-
ity to malaria and more severe conditions with recent in-
fections, which was not observed [6,51].
In a study of foetal biometry via umbilical artery and
uterine artery Doppler in women with vivax malaria in
Msambweni, Dent et al. concluded that earlier treatment
yielded fewer or even no effects throughout the gestation
[52]. Rikjen, studying ultrasound evidence of early foetal
growth restriction after maternal malaria infection,
found that intermittent preventive treatments are the
main strategy to prevent malaria, reduce anaemia and
low birth weight [53]. Schmiegelow, studying malaria
and foetal growth alterations in the third trimester of
pregnancy, concluded that the effects on foetal growth
often occurred after a considerable delay in women who
were diagnosed with malaria at the first antenatal visitand who subsequently strictly followed the antenatal
programme and the recommended measures to prevent
malaria infections [54]. Thus, active malaria screening
must be encouraged in pregnant women to ensure the
early implementation of treatment and obtain a low
morbidity rate and good perinatal outcomes.
The antenatal supplementation with daily iron is ef-
fective in reducing the risk of low birth weight [55,56].
This could also explain the lack of differences between
the two groups at the end of follow-up, as evidence of
the benefit of this supplementation, however this finding
needs further study in endemic areas, such as those in
Latin America. Another possible determinant of the lack
of major differences between the two groups was that
women initiated treatment very early, due to their easy
access to the health system in Manaus and surrounding
areas. This probably reinforces the impact of early diag-
nosis in endemic areas to this population.
It is worth noting that no changes in the demographic
data were observed among the groups of pregnant
women, suggesting that the groups were homogeneous
and that epidemiological factors were not confounding
factors in this study.
In the present study, the changes in the placental
thickness, although significant, did not cause foetal re-
percussions at birth. There were no morphological or
foetal changes that could be considered characteristic of
foetal involvement in vivax malaria. The fact that the
ultrasound examinations agreed with those from a co-
hort group of unexposed pregnant women was most
likely due to the area being of low endemicity, and
therefore, all pregnant women in the present study par-
ticipated in follow-ups in an active detection system that
allowed early diagnosis and treatment of new malarial
episodes. The treatment and control of infections and
relapses ensured that the behaviour of the infected group
was similar to that of the group of pregnant women
without malaria. In these study, malaria was an acute
and non-chronic event with acute consequences that, in
most cases, did not have any consequences and retreated
spontaneously after treatment, thus demonstrating the
benefits of adequate treatment and close follow-up of in-
fected cases. All women were treated with chloroquine,
and recent data showed that P. vivax chloroquine-
resistance is supposed to be around 5% [57].
Limitations of the present study were low power of the
study in order to estimate the frequency of low birth
weight in P. vivax infection; only thick blood smears
were performed; PCR to diagnose low parasitaemia
could not be performed; patients performed weekly
prophylaxis with chloroquine without supervision; some
infections such as syphilis, toxoplasmosis and rubella
were excluded because are routinely tested in antenatal
care, but other infections, although rare, were not
Brock et al. Malaria Journal  (2015) 14:144 Page 10 of 11excluded and could have lead to increased placental
thickness; the examinations were performed by an ultra-
sound examiner who was not blinded to the presence or
absence of infection, leading to bias. Furthermore, vari-
ables derived from ultrasound biometry followed the
Hadlock reference table from a North American popula-
tion, impairing a precise estimation in the Amazonian
population. However, using a control group this limita-
tion was surpassed.
Conclusions
The placental thickness changes were significant but
caused no foetal repercussions at birth. The ultrasound
findings except placental thickness were similar in both
groups, possibly because this is a low-endemic area and
the pregnant women in the study were followed up in an
active detection system that allowed early diagnosis and
treatment of new malaria episodes.
From the public health perspective, the finding of in-
creased placental thickness could be a sentinel marker of
malarial infection and this information could be useful
for those who perform ultrasound examinations in re-
mote areas, alerting the need of thick blood smear sys-
tematically. However, further studies in other areas are
needed to confirm this finding.
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